Spondyloarthritis & psoriatic arthritis

Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis—a systematic literature review and meta-analysis

Rheumatology (Oxford)Published Systematic review and meta-analysis of diagnostic accuracy studies

An erratum to this article was published (Rheumatology (Oxford), 1 Nov 2024 ↗)

Authors' conclusion

Imaging features and CRP have good diagnostic value for axSpA. However, the specificity of other features, especially HLA-B27 and IBP, is lower than previously known.

Study context

Population
Patients with suspected SpA46 studies included
Comparison
Clinical, laboratory and imaging SpA features vs rheumatologist's diagnosis of SpA (reference)
Outcome
Pooled sensitivity, specificity, LR+ and LR- of SpA features for diagnosing each SpA subtype
Methodological detailsmeta-regression, separate meta-analysis per SpA subtype, 13 844 articles screened
  • Meta-regression
  • Separate meta-analysis per SpA subtype
  • 13 844 articles screened

Pooled result

As reported in the abstract

Diagnostic performance for axial SpA (axSpA)
GroupLR+LR-
Sacroiliitis on MRI, pelvic radiograph damage, elevated CRP3.9-17.00.5-0.7
HLA-B273.1
Inflammatory back pain (IBP)≈10.3
Peripheral features and extramusculoskeletal manifestations1.6-5.0≈1

LR+

Sacroiliitis on MRI, pelvic radiograph damage, elevated CRP3.9-17.0
HLA-B273.1
Inflammatory back pain (IBP)≈1
Peripheral features and extramusculoskeletal manifestations1.6-5.0

LR-

Sacroiliitis on MRI, pelvic radiograph damage, elevated CRP0.5-0.7
HLA-B27— not stated in the abstract
Inflammatory back pain (IBP)0.3
Peripheral features and extramusculoskeletal manifestations≈1

Original publication

Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis—a systematic literature review and meta-analysis. Rheumatology (Oxford). Published 1 February 2024. doi:10.1093/rheumatology/keae065

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.